407 related articles for article (PubMed ID: 30697728)
21. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
22. A Critical Review of the Properties and Analytical Methods for the Determination of Curcumin in Biological and Pharmaceutical Matrices.
Carolina Alves R; Perosa Fernandes R; Fonseca-Santos B; Damiani Victorelli F; Chorilli M
Crit Rev Anal Chem; 2019; 49(2):138-149. PubMed ID: 30252504
[TBL] [Abstract][Full Text] [Related]
23. The suitability of liposomes for the delivery of hydrophobic drugs - A case study with curcumin.
Kolter M; Wittmann M; Köll-Weber M; Süss R
Eur J Pharm Biopharm; 2019 Jul; 140():20-28. PubMed ID: 31015019
[TBL] [Abstract][Full Text] [Related]
24. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin.
Kumar S; Kesharwani SS; Mathur H; Tyagi M; Bhat GJ; Tummala H
Eur J Pharm Sci; 2016 Jan; 82():86-96. PubMed ID: 26588875
[TBL] [Abstract][Full Text] [Related]
25. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
26. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
27. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
29. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method.
Shin GH; Chung SK; Kim JT; Joung HJ; Park HJ
J Agric Food Chem; 2013 Nov; 61(46):11119-26. PubMed ID: 24175657
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.
Zhang J; Tang Q; Xu X; Li N
Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117
[TBL] [Abstract][Full Text] [Related]
31. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
[TBL] [Abstract][Full Text] [Related]
32. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.
Mazzarino L; Borsali R; Lemos-Senna E
J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001
[TBL] [Abstract][Full Text] [Related]
33. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
[TBL] [Abstract][Full Text] [Related]
34. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
Kakkar V; Singh S; Singla D; Kaur IP
Mol Nutr Food Res; 2011 Mar; 55(3):495-503. PubMed ID: 20938993
[TBL] [Abstract][Full Text] [Related]
35. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
Mohanty C; Das M; Sahoo SK
Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
[TBL] [Abstract][Full Text] [Related]
36. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
37. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs.
Ni J; Tian F; Dahmani FZ; Yang H; Yue D; He S; Zhou J; Yao J
Drug Deliv; 2016 Nov; 23(9):3424-3435. PubMed ID: 27198856
[TBL] [Abstract][Full Text] [Related]
38. High-Payload Buccal Delivery System of Amorphous Curcumin-Chitosan Nanoparticle Complex in Hydroxypropyl Methylcellulose and Starch Films.
Lim LM; Hadinoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502305
[TBL] [Abstract][Full Text] [Related]
39. Chitosan Encapsulation Enhances the Bioavailability and Tissue Retention of Curcumin and Improves its Efficacy in Preventing B[a]P-induced Lung Carcinogenesis.
Vijayakurup V; Thulasidasan AT; Shankar G M; Retnakumari AP; Nandan CD; Somaraj J; Antony J; Alex VV; Vinod BS; Liju VB; Sundaram S; Kumar GSV; Anto RJ
Cancer Prev Res (Phila); 2019 Apr; 12(4):225-236. PubMed ID: 30760502
[TBL] [Abstract][Full Text] [Related]
40. Formulation of More Efficacious Curcumin Delivery Systems Using Colloid Science: Enhanced Solubility, Stability, and Bioavailability.
Zheng B; McClements DJ
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
